Kulkarni Sandeep Chidambar has filed 15 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 894000 shares of Zura Bio Ltd ($ZURA) on April 01, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Zura Bio Ltd | $ZURA | Kulkarni Sandeep Chidambar | Chief Executive Officer | A | Employee Share Option (Right to Buy) | 894000 | $0.00 | 894,000.0000 | 94,160,138 | 9999.99% | 0.95% |
| Jan. 21, 2026 | Zura Bio Ltd | $ZURA | Kulkarni Sandeep Chidambar | Chief Executive Officer | A | Employee Share Option (Right to Buy) | 2934107 | $0.00 | 2,934,107.0000 | 94,564,632 | 9999.99% | 3.10% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | U | Common Stock | 724664 | $0.00 | 30,387.0000 | 25,755,000 | 95.98% | 2.81% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | D | Common Stock | 30387 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.12% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | U | Common Stock | 7000 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.03% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | D | Employee Stock Option (Right to Buy) | 503478 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 1.95% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | D | Employee Stock Option (Right to Buy) | 254207 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.99% |
| Oct. 28, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | D | Employee Stock Option (Right to Buy) | 226000 | $0.00 | 0.0000 | 25,755,000 | 100.00% | 0.88% |
| Oct. 22, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | M | Common Stock | 25316 | $7.90 | 762,051.0000 | 25,755,000 | 3.44% | 0.10% |
| Oct. 22, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | M | Employee Stock Option (Right to Buy) | 25316 | $0.00 | 503,478.0000 | 25,755,000 | 4.79% | 0.10% |
| May 21, 2025 | Zura Bio Ltd | $ZURA | Kulkarni Sandeep Chidambar | Not found | A | Share Option (Right to Buy) | 51000 | $0.00 | 51,000.0000 | 92,964,048 | 9999.99% | 0.05% |
| Feb. 3, 2025 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | A | Employee Stock Option (Right to Buy) | 226000 | $0.00 | 226,000.0000 | 25,348,000 | 9999.99% | 0.89% |
| Dec. 9, 2024 | Zura Bio Ltd | $ZURA | Kulkarni Sandeep Chidambar | Not found | A | Share Option (Right to Buy) | 117000 | $0.00 | 117,000.0000 | 87,335,667 | 9999.99% | 0.13% |
| Aug. 21, 2024 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | P | Common Stock | 1779 | $14.85 | 7,000.0000 | 25,724,000 | 34.07% | 0.01% |
| Aug. 16, 2024 | Tourmaline Bio, Inc. | $TRML | Kulkarni Sandeep Chidambar | CEO | P | Common Stock | 5221 | $13.79 | 5,221.0000 | 25,724,000 | 9999.99% | 0.02% |